September 16, 2021 – Commercial Real Estate Neil Wahlgren and Whistleblower Chris Riedel

September 16, 2021 – Commercial Real Estate Neil Wahlgren and Whistleblower Chris Riedel

“The audio file was removed when we switched hosts. Sorry. The cost was prohibitive. If you need the file, contact us and we will send it.”

Neil Wahlgren – Chief Operating Officer of MAG Capital Partners 

Over the last three years, industrial has been the top performing commercial real estate class.

Neil Wahlgren CEO of MAG Capital Partners. Raising capital for direct investments into cash flowing NNN operational industrial real estate. Emphasis on mid-market, creditworthy manufacturing tenants. Sale leaseback transactions creating value through institutional leases and long-term alignment with proven tenants. Core values of integrity, punctuality, and attention to detail derived through background as a commissioned officer and pilot in the US Air Force & Navy. Specialties: Securitized commercial real estate investments with credit tenants through industrial sale leaseback acquisitions.

Chris Riedel – Author of Blood Money

The likelihood of whistle blowers succeeding is less than the
likelihood of being hit by lightning.

Chris Riedel has spent the past 40 years in the healthcare industry, and more recently, as one of the leading healthcare fraud fighters. He founded and served as the CEO of five health care companies: Hunter Heart, Hunter Laboratories, Meris Laboratories (NASDAQ: MERS), MicroScan, and Micro Media systems. In May of 1992, Meris was ranked by Business Week as the 40th best small company in America. He also has served as a Managing Director for Providence Capital, a boutique New York investment bank, as the Chairman of Chi Laboratory Systems, the pre-eminent hospital and commercial laboratory consulting firm in the U.S., and as a member of the Board of Directors of Boston Heart Lab. Currently, is he is member of Business Executives for National Security (BENS). For the past decade, Mr. Riedel has concentrated his efforts on fraud fighting against medical labs that are defrauding American taxpayers and the medical industry — the subject of Blood Money. One of his proudest accomplishments came when he received the Taxpayers Against Fraud Whistleblower of the Year Award in 2011 for assisting in the recovery of $286 million from Quest and LabCorp, which he undertook on behalf of California taxpayers. Another accomplishment was developing and receiving FDA new drug approval for a more precise way to identify bacteria causing disease, and which antibiotics and dosage will be most effective in treatment — a product that has saved many lives around the world. A longtime resident of Silicon Valley, Mr. Riedel makes his home there with his wife, Marcia, and four sons, for whom he served as a soccer and basketball coach for years. He enjoys international travel and is an avid Bay Area sports fan.